业绩总结 - 公司在2023财年实现了158%的年度调整后EBITDA增长，达到2.05亿美元[12] - 现金调整后的EBITDA从2021年到2023年有443百万美元的改善[13] - 经营活动现金流在年度上增长了4800万美元，增长了79%[14] - 公司在2023年实现了9%的现金调整后EBITDA[13] - 公司在2023年实现了79%的经营活动现金流增长[14] - 公司在2023年实现了158%的年度调整后EBITDA增长[12] 用户数据 - 2022年到2023年，Medicare单位经济略有下降，主要受到每个提交的销售额下降的影响[15] - 销售额每提交下降了5%，达到915美元[15] - 成本每提交下降了9%，达到747美元[15] - 2023年第四季度，公司Medicare每次提交的收入为$957，较2022年同期的$175有大幅增长[24] - 2023年全年，公司Medicare每次提交的收入为$866，较2022年的$623有增长[26] 未来展望 - 2023年第四季度，公司调整后的EBITDA为$75,091，较2022年同期的($129,776)有显著增长[18] - 2023年第四季度，公司调整后的净收入为$276,697，较2022年同期的$69,376有大幅增长[19] - 2023年全年，公司调整后的EBITDA为$75,091，较2022年的($129,776)有显著增长[20] - 2023年全年，公司调整后的净收入为$734,671，较2022年的$631,675有增长[20] - 2023年第四季度，公司调整后的EBITDA为$57,000，较2022年同期的($94,781)有增长[21] - 2023年全年，公司调整后的EBITDA为$75,091，较2022年的($129,776)有增长[22] - 2023年全年，公司调整后的EBITDA利润率为10.2%，较2022年的-20.5%有显著改善[22] 新产品和新技术研发 - 2022年第四季度，公司销售每次提交的成本为$596，较2022年第三季度的$866有显著下降[28]

Exhibit 99.1 GoHealth Reports Fourth Quarter and Fiscal 2023 Results CHICAGO, March 14, 2024 — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced unaudited financial results for the fourth quarter and year ended December 31, 2023. • The Company generated $109.1 million of cash flow from operations in 2023, a substantial 79.2% improvement compared to $60.9 million in the prior year period. • The perc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. ...

Third Quarter 2023 Results November 9, 2023 FORWARD-LOOKING STATEMENTS These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other thanstatements of historical facts contained in this Press Release may be forward-looking statements. Statements regarding the Company’s future results ofoperations and financial position, business strategy and plans and objectives of management for future operations, including, among others, st ...

财务数据和关键指标变化 - 第三季度收入为1.32亿美元,剔除往年调整和非Encompass BPO服务后同比增长12% [3][4] - 公司预计全年收入(不含非Encompass BPO服务)为8亿-8.5亿美元,调整后EBITDA为1.2亿-1.4亿美元,经营活动现金流为7.5亿-15亿美元 [5] - 第三季度提交量同比增长31%至16.1万件 [4] - 第三季度销售额/提交量同比下降15%,主要由于预期购买行为增加导致收入确认约束增加 [16][17] - 第三季度成本/提交量同比下降14%,体现了Encompass模式带来的运营效率提升 [17] 各条业务线数据和关键指标变化 - 非代理收入从去年同期的1.29亿美元增长至3.35亿美元,增长超过161% [3][4] - 非代理收入占比持续提升,体现了公司向Encompass模式转型的进展 [36][37] 各个市场数据和关键指标变化 - 无具体披露 公司战略和发展方向及行业竞争 - 公司正在投资技术,以满足不同消费者群体的个性化需求,包括电话、数字等多种互动方式 [26][27][28] - 公司的Encompass模式有利于提升代理效率、提供无偏见的个性化购买体验,与监管趋势一致 [28][29][30][31][32] - 公司正在加强代理培训和质量控制,确保代理推荐与消费者最佳利益一致 [33][34][35] 管理层对经营环境和未来前景的评论 - 公司看好未来增长前景,预计现金流和盈利能力将快速提升 [5] - 公司认为监管趋势有利于提升行业标准,消除不良行为,公司已提前采取措施与之保持一致 [28][29][30][31][32] 问答环节重要的提问和回答 问题1 **Sandeep Soorya 提问** 询问公司债务到期情况及未来管理策略 [9][10] **Jason Schulz 回答** 公司计划在2024年初对2025年9月到期的定期贷款和2024年9月到期的循环信贷进行再融资,并降低整体利率 [13] 问题2 **Sandeep Soorya 提问** 询问公司代理收入和非代理收入的构成及未来增长趋势 [14][15][16] **Vijay Kotte 回答** 未来非代理收入占比将持续提高,这反映了公司向Encompass模式转型的进展 [36][37] 问题3 **Greg Aurand 提问** 询问监管变化对公司的影响 [27][28][29][30][31][32] **Vijay Kotte 回答** 公司支持监管趋势,旨在保护消费者利益,公司已提前采取措施与之保持一致,相信最终会达成平衡 [28][29][30][31][32]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. ...

GoHealth, Inc. (NASDAQ:GOCO) Q2 2023 Earnings Conference Call August 10, 2023 8:00 AM ET Company Participants John Shave - VP, IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Ben Hendrix - RBC Capital Markets Operator Good day and thank you for standing by. Welcome to the GoHealth Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39390 GoHealth, Inc. ...

GoHealth, Inc. (NASDAQ:GOCO) Q1 2023 Earnings Conference Call May 8, 2023 8:00 AM ET Company Participants John Shave - VP of IR Vijay Kotte - CEO Jason Schulz - CFO Conference Call Participants Mike Cherny - Bank of America Jonathan Yong - Credit Suisse Ben Hendrix - RBC Capital Markets Operator Good morning, and welcome to the GoHealth First Quarter 2023 Earnings Conference Call. My name is Michelle, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Fol ...

| --- | --- | |-----------------------------|-------| | | | | | | | First Quarter 2023 Results | | | MAY 8, 2023 | | FORWARD-LOOKING STATEMENTS These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Statements regarding the Company's future results of operations and financial position, business strategy and plans and ...